The primary object of the proposal is to continue the studies of the structure, function and trafficking of human lysosomal membrane glycoproteins. In the past few years, we have greatly advanced our knowledge of two related major lysosomal membrane glycoproteins, lamp-1 and lamp-2. In particular, we now know about their growth structures, the roles of carbohydrates in their stability, and the critical involvement of the cytoplasmic tyrosine in their lysosomal delivery. By studying another lysosomal membrane glycoprotein, Limp II, a novel Leu-IIe motif was identified as a lysosomal delivery signal. We have also demonstrated that highly metastic tumor cells express more lamp molecules than low metastic cells and that the higher the amount of cell surface lamp molecules, the stronger the adhesion to activated endothelial cells. Such adhesion was found to be inhibited by a soluble lamp-1 containing sialyl Le-x structure. Based on these findings, three major areas for further study are the following: 1) Elucidation of critical structural elements for maintaining the stability of lamp-1 and lamp-2. The studies will involve replacing various domains of lamp molecules in order to identify the structural elements important for the stability of lamp molecules. In particular, the roles of O-glycans and the hinge-region will be addressed. 2) Elucidation of roles of carbohydrates attached to lamp molecules in tumor metastasis. The studies will determine if those tumor cells expressing more lamp molecules on the cell surface are more metastatic, and if metastasis can be inhibited by a soluble lamp-1 containing sialyl Le-x structures. 3) Further understanding of trafficking of lysosomal membrane glycoproteins. The studies will further elucidate the critical amino acid residues involved in newly discovered Tyr-containing and Leu-IIe containing motifs for lysosomal delivery. The studies will also be aimed at differentiating the two sorting pathways to lysosomes; direct intracellular sorting versus the endocytosis pathway via the plasma membrane.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA048737-05
Application #
3192671
Study Section
Pathology B Study Section (PTHB)
Project Start
1989-08-01
Project End
1998-05-31
Budget Start
1993-06-15
Budget End
1994-05-31
Support Year
5
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
009214214
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Yoneyama, Tohru; Angata, Kiyohiko; Bao, Xingfeng et al. (2012) Fer kinase regulates cell migration through ?-dystroglycan glycosylation. Mol Biol Cell 23:771-80
Kobayashi, Motohiro; Hoshino, Hitomi; Suzawa, Kenichi et al. (2012) Two distinct lymphocyte homing systems involved in the pathogenesis of chronic inflammatory gastrointestinal diseases. Semin Immunopathol 34:401-13
Shimojo, Hisashi; Kobayashi, Motohiro; Kamigaito, Takayuki et al. (2011) Reduced glycosylation of ?-dystroglycans on carcinoma cells contributes to formation of highly infiltrative histological patterns in prostate cancer. Prostate 71:1151-7
Bao, Xingfeng; Fukuda, Minoru (2010) A tumor suppressor function of laminin-binding alpha-dystroglycan. Methods Enzymol 479:387-96
Mitoma, Junya; Fukuda, Minoru (2010) Core O-glycans required for lymphocyte homing gene knockout mice of core 1 beta1,3-N-acetylglucosaminyltransferase and core 2 N-acetylglucosaminyltransferase. Methods Enzymol 479:257-70
Kobayashi, Motohiro; Hoshino, Hitomi; Masumoto, Junya et al. (2009) GlcNAc6ST-1-mediated decoration of MAdCAM-1 protein with L-selectin ligand carbohydrates directs disease activity of ulcerative colitis. Inflamm Bowel Dis 15:697-706
Mitoma, Junya; Miyazaki, Tatsuo; Sutton-Smith, Mark et al. (2009) The N-glycolyl form of mouse sialyl Lewis X is recognized by selectins but not by HECA-452 and FH6 antibodies that were raised against human cells. Glycoconj J 26:511-23
Kobayashi, Motohiro; Fukuda, Minoru; Nakayama, Jun (2009) Role of sulfated O-glycans expressed by high endothelial venule-like vessels in pathogenesis of chronic inflammatory gastrointestinal diseases. Biol Pharm Bull 32:774-9
Lee, Seung Ho; Hatakeyama, Shingo; Yu, Shin-Yi et al. (2009) Core3 O-glycan synthase suppresses tumor formation and metastasis of prostate carcinoma PC3 and LNCaP cells through down-regulation of alpha2beta1 integrin complex. J Biol Chem 284:17157-69
Bao, Xingfeng; Kobayashi, Motohiro; Hatakeyama, Shingo et al. (2009) Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase. Proc Natl Acad Sci U S A 106:12109-14

Showing the most recent 10 out of 76 publications